EU Grants Approval to Corynebacterium stasis KCCM 80235-Derived Disodium Inosinate as a Universal Animal Feed Additive
In a recent development outlined in the Official Journal of the European Union, the European Commission has enacted Regulation (EU) No. 2023/2632 on November 28, 2023. This regulation greenlights the use of Corynebacterium stasis KCCM 80235 in adherence to Regulation (EC) No 1831/2003 of the European Parliament and of the Council. Specifically, it approves the incorporation of Disodium 5'-inosinate as a feed additive for all animals.
According to the stipulations outlined in the accompanying document, this additive receives authorization within the category of "sensory additives" and falls under the functional group of "flavoring compounds." The approved period for this authorization extends until December 18, 2033. The enacted regulations come into effect on the twentieth day following their official promulgation. This marks a significant milestone in the regulatory landscape surrounding animal feed additives within the European Union.
2026-10-10
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
TSMC, Samsung, and SK Hynix Scramble for Electronic-Grade Hydrofluoric Acid as High-End Supply Tightens; Some Suppliers Raise Prices by 30% This Year
-
When the Skin of Ships Gets More Expensive: A 30% Price Shock Is Quietly Rewriting the Cost Floor of Global Shipping
-
Platinum Chemotherapy Shortages Expose the Fragility of Essential API Supply
-
Fertilizer Costs Rise as Middle East Tensions Pressure Global Food Production
-
Fertilizer Costs Rise as Middle East Tensions Pressure Global Food Production
-
Stahl Reopens Ranipet Plant
-
UAE Withdraws from OPEC
-
Middle East Conflict Hits the Electronics Supply Chain as PPE Resin Shortage Sends PCB Prices Up 40%
-
Indonesia’s Plastic Prices Jump 50%–100% as Government Moves to Remove Import Duties
-
Butadiene Rubber's Cost in China Floor Collapses, Exports Hold the Line
Recommend Reading
-
Indian Immunologicals Pushes Back on “Fake Vaccine” Claims Amid Global Supply Chain Scrutiny
-
Obesity Drugs Become Pharma’s Most Powerful Growth Engine
-
ARLANXEO Launches State-of-the-Art HNBR Plant in Changzhou, Strengthening Asia-Pacific Supply
-
Substandard Drug Findings Expose Deep Structural Gaps in Medicine Quality Control
-
Minoxidil Safety Under Global Review as Infant Exposure Risks Surface
-
Supply and Demand Easing Coupled with Bearish Moving Averages, Melamine Spot Prices Continue to Weaken in China
-
Sodium Percarbonate: Uses, Benefits, and Safety
-
Business Society’s PTA Market Outlook on August 18, 2026: Rising
-
TBHQ: Uses, Safety, and Health Effects
-
Business Society’s LDPE Market Outlook on August 18, 2026: Volatile